Merck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui ...

Revenue from land sales in 300 major Chinese cities jumped 19.3 percent in the two months ended Feb. 28 from a year ago, ...

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

A Chinese street food malatang outlet, YangGuoFu Malatang in Suzhou, East China's Jiangsu Province, was ordered to shut down ...

To mark this exciting milestone, @Visit Jiangsu has launched a dazzling array of "Happy Chinese New Year 2025" festive events across Facebook, X, Instagram, YouTube, and TikTok as part of the ...

(Photo by Zhan Zheng/Xinhua) Chinese President Xi Jinping on Wednesday urged east China's Jiangsu Province, an economic powerhouse, to play a major role in the country's overall development.

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, ...

The Chinese national football team now needs to secure consecutive wins to keep their World Cup hopes alive, after suffering ...